Back

Blockers of Hyperpolarization-activated Cyclic Nucleotide-gated channels exhibit antimuscarinic properties in human atrial cardiomyocytes

29 April 2022 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster Session 1 Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Miss Valentina Balducci

University of Florence, Florence (Italy)

73 More presentations in this session

Presentation thumbnail
Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients
Miss E. Bevilacqua (Seville, ES)
Abstract
Presentation thumbnail
Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring
Doctor K. Viligorska (Chernivtsi, UA)
Abstract
Presentation thumbnail
Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study
Mr C. Rios Navarro (Valencia, ES)
Abstract
Presentation thumbnail
Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion
Associate Professor L. Tacu (Chisinau, MD)
Presentation thumbnail
Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets
Doctor B. Agg (Budapest, HU)
Abstract

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

29 April 2022 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Long-term effects of hyperpolarization-activated inward current blockade on cardiac parasympathetic activity
25 April 2021
thumbnail
Congress Presentation
Human atrium-sized in vitro modelling of atrial fibrillation: a new experimental scale for preclinical therapeutic testing
12 April 2026
thumbnail
Congress Presentation
Acetylcholine coronary vasospastic responses evaluated via a hydrodynamic model
1 September 2025
thumbnail
Congress Presentation
Betablockers or calcium channel blockers in hypertrophic cardiomyopathy
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources